Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...

Eli Lilly sued four telehealth firms, but it is adopting a new legal strategy in its fight against compounded GLP-1s.

Eli Lilly and digital health firm Livongo are to ... data to advance knowledge about effective interventions in diabetes care. Goals include measuring the impact of remote diabetes self-management ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for ... last year, Eli Lilly has been ...

Scientists at Sanford Burnham Prebys and Eli Lilly and Company published findings March 5, 2025, in the Journal of Immunology demonstrating that fusing protein complexes together adds stability ...

Alzheimer’s patients won’t be able to order treatments, such as Lilly’s newly launched drug Kisunla, since they’re given as infusions in medical facilities.